Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Tinzaparin may stop the growth of kidney cancer by blocking blood flow to the
tumor.
PURPOSE: This phase I/II trial is studying the side effects of tinzaparin and to see how well
it works in treating patients with metastatic kidney cancer that cannot be removed by
surgery.